BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 5:49:41 AM | Browse: 134 | Download: 555
 |
Received |
|
2025-05-13 05:05 |
|
Peer-Review Started |
|
2025-05-13 05:06 |
|
First Decision by Editorial Office Director |
|
2025-05-22 10:13 |
|
Return for Revision |
|
2025-05-22 10:13 |
|
Revised |
|
2025-06-02 04:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-16 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-16 09:45 |
|
Articles in Press |
|
2025-07-16 09:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-01 01:30 |
|
Publish the Manuscript Online |
|
2025-08-14 05:49 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhe Wang, Rui-Ying Zhang, Yi-Fan Xu, Bing-Tong Yue, Jia-Yi Zhang and Feng Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Feng Wang, MD, PhD, Professor, Senior Researcher, Senior Scientist, Oncology, The First Affiliated Hospital of Zhengzhou University, No.50 Eastern Jianshe Road, Zhengzhou 450052, Henan Province, China. zzuwangfeng@zzu.edu.cn |
| Key Words |
Esophageal squamous cell carcinoma; Immunotherapy resistance; Tumor microenvironment; Immune checkpoint blockade; Biomarkers |
| Core Tip |
Esophageal squamous cell carcinoma (ESCC) poses significant clinical challenges due to its aggressive progression and poor survival outcomes. While immunotherapy offers promise, resistance—both primary and acquired—remains a major hurdle, limiting its efficacy. This review explores the mechanisms of immunotherapy resistance in ESCC, including immunosuppressive cells, inhibitory cytokines, and molecular alterations in programmed death 1/programmed death-ligand 1 signaling. We also examine emerging strategies to overcome resistance, such as combination therapies and tumor microenvironment remodeling, emphasizing the need for predictive biomarkers to improve patient outcomes. |
| Publish Date |
2025-08-14 05:49 |
| Citation |
Wang Z, Zhang RY, Xu YF, Yue BT, Zhang JY, Wang F. Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape. World J Gastrointest Oncol 2025; 17(8): 109489 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i8/109489.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i8.109489 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
